Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival.
Saved in:
| Title: | Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival. |
|---|---|
| Authors: | Genßler, Sabrina1, Burger, Michael C.2,3,4, Zhang, Congcong1,3,4, Oelsner, Sarah1, Mildenberger, Iris1,2, Wagner, Marlies5, Steinbach, Joachim P.2,3, Wels, Winfried S.1,3 |
| Source: | OncoImmunology. 2016, Vol. 5 Issue 4, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
